We like to highlight the whole range of research at The Children’s Hospital of Philadelphia, from basic discoveries at the lab bench to clinical findings applied at the patient’s bedside. But we have an abundance of updates to share today about the clinical side of research.
Tag Archive: Cancer
Check out the most exciting research news from The Children’s Hospital of Philadelphia this week. From leading a group of international researchers who identified a new syndrome to working on a prestigious panel that will give guidance about ways to advance treatments for children with cancer, CHOP researchers are putting pediatric research in motion.
New findings in cancer immunotherapy, controversy over recommendations for universal autism screening, and Zika virus are among this week’s highlights.
Dr. Tan, a cancer genomics and bioinformatics researcher, joined The Children’s Hospital of Philadelphia in January. Within weeks of his arrival, Vice President Joe Biden launched the cancer “moonshot” initiative during a visit with cancer researchers from the University of Pennsylvania and CHOP at Penn’s Abramson Cancer Center.
Cancer genetics and collaboration were big themes in this week’s news featuring research at The Children’s Hospital of Philadelphia. Check out our weekly summary of some of the developments this first week of February.
Research at The Children’s Hospital of Philadelphia never stops. To help keep you informed about new discoveries and CHOP researchers’ views on timely topics, we are bringing together a roundup of news highlights. Look for this as a recurring feature here on Cornerstone.
Researchers at The Children’s Hospital of Philadelphia reported their latest results from their studies of an investigational personalized cell therapy for a highly aggressive form of cancer, acute lymphoblastic leukemia (ALL).
Beckwith-Wiedemann Syndrome (BWS) is a condition that occurs when parts of the body grow too large, too fast.
Peter C. Adamson, MD, a pediatric oncologist and leading scientist at The Children’s Hospital of Philadelphia, and a professor of Pediatrics and Pharmacology at the Perelman School of Medicine at the University of Pennsylvania, has been appointed by President Obama to the National Cancer Advisory Board.
Researchers from CHOP are exploring how biodegradable nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma, an often-deadly children’s cancer.